Cystic fibrosis and primary ciliary dyskinesia: Similarities and differences

Respir Med. 2023 Apr:209:107169. doi: 10.1016/j.rmed.2023.107169. Epub 2023 Feb 22.

Abstract

Cystic fibrosis (CF) and Primary ciliary dyskinesia (PCD) are both rare chronic diseases, inherited disorders associated with multiple complications, namely respiratory complications, due to impaired mucociliary clearance that affect severely patients' lives. Although both are classified as rare diseases, PCD has a much lower prevalence than CF, particularly among Caucasians. As a result, CF is well studied, better recognized by clinicians, and with some therapeutic approaches already available. Whereas PCD is still largely unknown, and thus the approach is based on consensus guidelines, expert opinion, and extrapolation from the larger evidence base available for patients with CF. Both diseases have some clinical similarities but are very different, necessitating different treatment by specialists who are familiar with the complexities of each disease.This review aims to provide an overview of the knowledge about the two diseases with a focus on the similarities and differences between both in terms of disease mechanisms, common clinical manifestations, genetics and the most relevant therapeutic options. We hoped to raise clinical awareness about PCD, what it is, how it differs from CF, and how much information is still lacking. Furthermore, this review emphasises the fact that both diseases require ongoing research to find better treatments and, in particular for PCD, to fill the medical and scientific gaps.

Keywords: Clinical awareness; Cystic fibrosis (CF); Mucociliary clearance; Primary ciliary dyskinesia (PCD); Rare diseases.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chronic Disease
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / genetics
  • Humans
  • Kartagener Syndrome* / complications
  • Kartagener Syndrome* / diagnosis
  • Kartagener Syndrome* / genetics
  • Prevalence